Lara Roberts/LinkedIn
Oct 16, 2025, 06:13
Lara Roberts Published “Anticoagulation in Cirrhosis: The New Standard”
Nazim Arain, Consultant Internal Medicine & Gastroenterologist at Almana Group of Hospitals, shared a post on LinkedIn:
“Anticoagulation in Cirrhosis: The New Standard
Patients with cirrhosis face an increased risk of thrombotic events like AF and VTE.
It’s now accepted that their coagulation is “rebalanced,” making anticoagulation the standard of care to reduce stroke/thrombosis risk!
The primary bleeding risk is linked to portal hypertension, NOT general clotting deficiency.
Direct Oral Anticoagulants (DOACs) can be considered for Child-Pugh A & B patients.
LMWH often preferred in Child-Pug-C.”
Title: Anticoagulation in cirrhosis
Authors: Lara Roberts

Read the full review here.
Stay updated with Hemostasis Today.
-
Jul 15, 2026, 07:15Sandrine Horman: Back From an Inspiring Week at ISTH 2026
-
Jul 15, 2026, 06:55Christopher Devany: Great to Be Here in Paris for the ISTH 2026
-
Jul 15, 2026, 06:45Viviana Di Fabio: The Synergy Between Hematology and Hemostasis Starts with Platelets
-
Jul 15, 2026, 06:35Wolfgang Miesbach: Paediatric Phase 3 BASIS KIDS Data for Marstacimab at ISTH 2026
-
Jul 15, 2026, 06:06Marija Tashkovska: Advancing Knowledge and Clinical Practice Through ISTH 2026
-
Jul 15, 2026, 05:55Hong Chow: Where Science Meets Art at ISTH 2026
-
Jul 15, 2026, 05:47Maria Magnusson: Advancing Hemostasis and Thrombosis Through Science and Collaboration at ISTH 2026
-
Jul 15, 2026, 05:32Alessandro Ciarcia: Connecting Expertise and Innovation to Transform the Future of TTP Management at ISTH 2026
-
Jul 15, 2026, 05:02Louise St. Germain Bannon: Scientific Collaboration at ISTH 2026